In Canada, we know that Bill C-6 was unfortunately withdrawn. We hope that the bill will soon be revived so that Canada may have a legislative framework comparable to that of the European Union.
I now come to the issue of convergence. I would simply like to point out the areas of convergence between the European Union and Canada. If we consider only those measures that have been implemented today, i.e., concrete measures, we find that there is not much of a difference between the European Union and Canada in the area of nanotechnologies, since there are no general regulations, with the exception—as I have already indicated—of the cosmetics and food additive industries—but there is not enough time for me to address that.
There is no common definition or classification of nanomaterials. Neither is there any pre-market control mechanism. Risk assessment methods are somewhat inadequate. There is no mandatory labelling and no transparency in terms of nanotechnology uses and applications. All of those issues are unanimously recognized as priorities on which we have to start working. All experts agree on that.
Thank you.